Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2012
07/10/2012US8217001 Modification of feeding behavior
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/10/2012US8216569 Vascular endothelial growth factor 2
07/10/2012CA2638081C Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
07/10/2012CA2624921C Nutritional formulation for promoting catch-up growth
07/10/2012CA2592995C 1-thio-d-glucitol derivatives
07/10/2012CA2562535C 2-alkylidene-18,19-dinor-vitamin d compounds
07/10/2012CA2533749C Piperidine compounds useful as malonyl-coa decarboxylase inhibitors
07/10/2012CA2510893C Binding agents which inhibit myostatin
07/10/2012CA2494915C Female hormone-containing patch
07/10/2012CA2467102C Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2446951C Polythiourea lipid derivatives
07/10/2012CA2446356C Use of compositions for treating rosacea
07/10/2012CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
07/10/2012CA2437940C Methods of treating diabetes mellitus
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
07/10/2012CA2211324C Recombinant human alpha-fetoprotein and uses thereof
07/05/2012WO2012091571A2 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091549A1 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091542A1 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091425A2 Composition containing a 4-hydroxytamoxifen analog or the pharmaceutically acceptable salts thereof as an active ingredient for preventing or treating diseases associated with metabolic syndrome
07/05/2012WO2012091372A2 Caffeine tape for body slimming
07/05/2012WO2012091041A1 Insulin secretion promoter
07/05/2012WO2012091010A1 Bicyclic pyrimidine derivative
07/05/2012WO2012090505A1 Milk-added, low-calorie black tea beverage
07/05/2012WO2012090005A1 Agonists of toll like receptor for treating cardiovasuclar disease and obesity
07/05/2012WO2012089607A1 Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
07/05/2012WO2012089606A1 Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists
07/05/2012WO2012089137A1 Arylurea compound, intermediate and use thereof
07/05/2012WO2012089127A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012089123A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012089122A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012088682A1 2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
07/05/2012WO2012088680A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012088677A1 Certain dipeptidyl peptidase inhibitors
07/05/2012WO2012088647A1 Deuterated acid addition salt of sitaliptin
07/05/2012WO2012063985A3 Hamburger for cholesterol reduction and manufacturing method therefor
07/05/2012WO2012048125A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
07/05/2012WO2012030165A3 Use of the fetal reprogramming of a ppar δ agonist
07/05/2012WO2012028622A3 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
07/05/2012WO2012006598A3 Stabilized insulinotropic peptides and methods of use
07/05/2012WO2011085643A8 Fused pyridine derivatives
07/05/2012WO2011010174A8 Crystalline form i rosuvastatin zinc salt
07/05/2012US20120174243 SOGA Polynucleotides and Polypeptides and Uses Thereof
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172444 Use of Conjugated Linoleic Acid
07/05/2012US20120172434 Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
07/05/2012US20120172432 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
07/05/2012US20120172426 Compositions, Synthesis, and Methods of Using Cycloalkylmethylamine Derivatives
07/05/2012US20120172417 System And Method For Identifying And Applying Peripheral Treatment Mechanisms For Disease
07/05/2012US20120172405 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
07/05/2012US20120172401 Benzimidazole derivative and use as angiotensin ii antagonist
07/05/2012US20120172400 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
07/05/2012US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof
07/05/2012US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use
07/05/2012US20120172391 Naphthyridinone analogs as mglur5 positive allosteric modulators
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172369 Inhibitors of diacylglycerol acyltransferase
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172358 GPCR Agonists
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172351 Novel fused cyclic compound and use thereof
07/05/2012US20120172350 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/05/2012US20120172344 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications
07/05/2012US20120172340 Compositions and Methods for Selectively Activating Human Sirtuins
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172335 Substituted benzimidazolone derivatives, medicaments comprising them and their use
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120172320 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
07/05/2012US20120172300 Remodeling and glycopegylation of fibroblast growth factor (fgf)
07/05/2012US20120172298 Glp-1 and fgf21 combinations for treatment of diabetes type 2
07/05/2012US20120172297 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases
07/05/2012US20120172296 Water-soluble aie luminogen for monitoring and retardation of amyloid fibrillation of insulin
07/05/2012US20120172295 Gip receptor-active glucagon compounds
07/05/2012US20120172294 Treatment of diseases
07/05/2012US20120172293 Peptide and use thereof
07/05/2012US20120171315 Active substance for improving hyperlipidemia and hypercholesterolemia
07/05/2012US20120171311 Substances for reducing occurrence of major cardiac events comprising epa or derivatives thereof, optionally, dha or derivatives thereof and monacolin k
07/05/2012US20120171310 Plant essential oil-based antimicrobial fish filming compositions and methods of use
07/05/2012US20120171309 Formulations and methods for increasing efficacies and improving flavors of formulations containing gynostemma plant
07/05/2012US20120171307 Magnesium Compositions and Uses Thereof for Neurological Disorders
07/05/2012US20120171291 Peptide-carrying nanoparticles
07/05/2012US20120171285 Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171280 Method of making liposomes, liposome compositions made by the methods, and methods of using the same
07/05/2012US20120171262 Pharmaceutical formulations
07/05/2012US20120171259 Orally absorbed pharmaceutical formulation and method of administration
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171221 Biomarkers for the early detection of autoimmune diseases
07/05/2012US20120171217 Monoclonal Antibodies Against ANGPTL4
07/05/2012US20120171216 Palmitated monoclonal antibody
07/05/2012US20120171212 Therapeutic compositions and methods for the prevention of autoimmune diseases
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 1298